AMGEN ANNOUNCES WEBCAST OF 2026 SECOND QUARTER FINANCIAL RESULTS
Rhea-AI Summary
Amgen (NASDAQ:AMGN) will report its second quarter 2026 financial results on Tuesday, August 4, 2026, after the close of U.S. financial markets, followed by an investor conference call at 4:30 p.m. ET with CEO Robert A. Bradway and senior management.
A live audio webcast, along with other selected management presentations, will be accessible via the Investors section of Amgen's website and listed on the Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days.
Positive
- None.
Negative
- None.
Key Figures
Previous Earnings Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 30 | Q1 earnings results | Positive | -4.8% | Reported Q1 revenue, earnings, margins, cash flow, and full-year 2026 guidance. |
| Apr 24 | Q1 webcast notice | Neutral | -1.3% | Scheduled first-quarter results and a 4:30 p.m. ET conference call. |
| Feb 03 | Q4 earnings results | Positive | +8.2% | Reported full-year revenue growth, EPS, cash flow, impairment, and mixed product performance. |
| Jan 28 | Q4 webcast notice | Neutral | +0.2% | Scheduled fourth-quarter and full-year results with a 4:30 p.m. ET call. |
| Nov 04 | Q3 earnings results | Positive | +7.8% | Reported Q3 revenue, EPS, margins, free cash flow, debt retirement, and reiterated guidance. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Tag-specific earnings history showed mixed reactions, including a -4.75% move after positive Q1 2026 results and positive reactions after prior quarterly reports.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.
The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines.
More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat cancer, inflammatory conditions, rare diseases, heart disease and obesity and obesity-related conditions.
Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.
For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, YouTube, Facebook, TikTok and Threads.
CONTACT: Amgen,
Elissa Snook, 609-251-1407 (media)
Casey Capparelli, 805-447-1746 (investors)
View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2026-second-quarter-financial-results-302836979.html
SOURCE Amgen